REPORT SCOPE & OVERVIEW
The Nucleotide Market size was estimated USD 597.2 million in 2022 and is expected to reach USD 944.6 million by 2030 at a CAGR of 5.9% during the forecast period of 2023-2030.
Nucleotides are the basic components of nucleic acids. A nucleotide is made up of a sugar molecule (ribose in RNA and deoxyribose in DNA) that is coupled to a phosphate group and a nitrogen-containing base.
Growing interest in newborn formula and sports nutrition products
Rising demand for infant formula and sports nutrition products is one of the primary reasons driving the nucleotide market revenue development. Nucleotides are known as being particularly important in newborn feeding due to their support for the immune system and gastrointestinal health. Birth rates are increasing in poor nations, and consumers are becoming more aware of the benefits of nucleotide-based infant formula. Furthermore, nucleotides are used in sports nutrition products to improve athletic performance and muscle recovery. The increased demand for sports nutrition products among fitness enthusiasts and athletes is driving revenue growth in the nucleotide market.
The high cost of nucleotides
The high cost of nucleotides is one of the most significant business constraints. Nucleotides are more expensive than other substances used in food and medicine due to their labor-intensive and costly manufacturing method. The use of nucleotides is limited in various applications due to their high cost, which may inhibit market revenue growth.
Increasing need for plant-derived nucleotides
The market is expected to find profitable potential as a result of increased demand for plant-based nucleotides. Plant-based nucleotides are being used in place of animal-based nucleotides due to their sustainability and environmental friendliness. The food industry's demand for plant-based nucleotides is predicted to rise in response to increased demand for vegan and vegetarian food products. Furthermore, market revenue growth is predicted to accelerate due to rising use of nucleotides in the animal feed sector. Nucleotides are added to animal feed to boost immune system performance and promote growth. The market for nucleotide-based animal feed is predicted to rise in tandem with increased demand for premium meat and dairy products.
The lack of understanding about the benefits of nucleotides
In developing countries, there is a lack of understanding regarding the benefits of nucleotides. The low penetration of nucleotide-based products in underdeveloped economies limits market revenue growth. Another factor impeding market revenue growth is the lack of regulatory approval for nucleotide-based products in some regions.
IMPACT OF RUSSIAN UKRAINE WAR
In the current Ukraine-Russia crisis to feed livestock with alternate raw materials is unavoidable. Aside from the cost of raw materials, the poultry industry faces numerous problems. The industry must do right away is focus on controlling poultry gut health and protecting it from numerous mycotoxins. Because the intestine contains over 70% of the immune system of chickens, managing gut health is critical.
IMPACT OF ONGOING RECESSION
The pharmaceutical industry will continue to experience rising operational expenses, severe rivalry, and patent expirations. Furthermore, a recession can affect pharmaceutical manufacturing and supply systems. The survey also identified increased drug pricing control over the last year as a major concern that industry professionals fear will hinder pharma growth, but this is a contentious issue.
In 2022, purine segment is accounted the largest market share during the forecast period. Purine nucleotides enable the production of adenosine triphosphate (ATP), a vital source of energy for living things. Pyrimidine nucleotides are required for the production of RNA and DNA, which are required for the transmission of genetic information. Purine nucleotides are used in a variety of goods, including food additives, animal feed, and pharmaceuticals. Purine nucleotides are projected to have an increase in demand in the coming years due to their rising application in the food industry. Purine nucleotides are commonly used as flavor enhancers in processed meals and beverages as convenience foods become more popular.
Food and Beverages
In 2022, the food and beverages segment is expected to held the highest market share during the forecast period This could be attributed to increased interest in functional foods and dietary supplements, as well as increased demand for natural and organic food products. Nucleotides are extensively used as flavor enhancers in food and beverages, and their demand is predicted to expand as a result of the growing popularity of processed foods and ready-to-eat meals.
Asia Pacific held a significant market share in 2022 owing to rising demand for nucleotides in the pharmaceutical and food industries in countries such as China, India, and Japan. The growing population, rising disposable incomes, and more consumer awareness of health issues are driving demand for nucleotides in this region. In the constantly increasing food sector of the region, nucleotides are being used more frequently to improve the nutritional value of food products and to enhance flavor. Furthermore, the region's pharmaceutical sector is rapidly expanding, which will enhance demand for nucleotides as Active Pharmaceutical Ingredients (APIs) and intermediates.
North America is witness to expand fastest market share during the forecast due to the increasing demand for nucleotides in the pharmaceutical and nutraceutical industries is driving market revenue growth in this area. The increased prevalence of chronic diseases such as cancer and diabetes in the United States, the region's largest consumer of nucleotides, is likely to drive up demand for nucleotide-based medications. Rising demand for functional meals and nutritional supplements is also predicted to drive the region's need for nucleotides.
Rest of Eastern Europe
Rest of Western Europe
Rest of Asia Pacific
Middle East & Africa
Rest of Middle East
Rest of Africa
Rest of Latin America
The major key players are CJ CheilJedang Corporation, Star Lake Bioscience Co., Inc, ThermoFisher Scientific Inc., Meihua Group, F. Hoffmann-La Roche Ltd, Ajinomoto Co. Inc, DSM Nutritional Products Ltd., Promega Corporation, Affymetrix Inc., Agilent Technologies Inc., Nanjing BioTogether Co., Ltd., NuEra Nutrition and Ohly GmbH, Glanbia Nutritional, and Others.
Agilent Technologies Inc-Company Financial Analysis
In 2021, Glanbia Nutritionals has introduced OptiSol 1000, a new line of nucleotide-based products.These ingredients are intended to enhance the texture and stability of plant-based meat substitutes such as burgers, sausages, and nuggets. They also improve these items' nutritional profile.
June 2022, Thermo Fisher Scientific demonstrated solutions for accelerating next-generation vaccine and therapeutic research and gaining deeper analytical insights.
Ajinomoto Co., Inc. invested in SuperMeat, a cultured meat firm that will leverage cellular agriculture technologies to build a sustainable food system, in March 2022.
|Market Size in 2022||US$ 597.2 Million|
|Market Size by 2030||US$ 944.6 Million|
|CAGR||CAGR of 5.9 % From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Type (Purine, Pyrimidine)
• By Application (Food and Beverages, Pharmaceuticals, Animal Feed, Others)
|Regional Analysis/Coverage||North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)|
|Company Profiles||CJ CheilJedang Corporation, Star Lake Bioscience Co., Inc, ThermoFisher Scientific Inc., Meihua Group, F. Hoffmann-La Roche Ltd, Ajinomoto Co. Inc, DSM Nutritional Products Ltd., Promega Corporation, Affymetrix Inc., Agilent Technologies Inc., Nanjing BioTogether Co., Ltd., NuEra Nutrition and Ohly GmbH, Glanbia Nutritional|
|Key Drivers||• Growing interest in newborn formula and sports nutrition products|
|Market Restrain||• The high cost of nucleotides|
Ans: Nucleotide market is anticipated to expand by 5.9% from 2023 to 2030.
Ans: The growth rate of nucleotide market is expected to grow USD 944.6 million by 2030.
Ans: Nucleotide market size was valued at USD 597.2 million in 2022.
Ans: Asia Pacific segment is expected to held the highest market share in 2022.
Ans: Increasing need for plant-derived nucleotides
TABLE OF CONTENT
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.2 Impact on major economies
184.108.40.206 United Kingdom
220.127.116.11 South Korea
18.104.22.168 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Nucleotide Market Segmentation, By Type
9. Nucleotide Market Segmentation, By Application
9.1 Food and Beverages
9.3 Animal Feed
10. Regional Analysis
10.2 North America
10.2.1 North America Nucleotide Market by Country
10.2.2 North America Nucleotide Market by Type
10.2.3 North America Nucleotide Market by Application
10.2.4.1 USA Nucleotide Market by Type
10.2.4.2 USA Nucleotide Market by Application
10.2.5.1 Canada Nucleotide Market by Type
10.2.5.2 Canada Nucleotide Market by Application
10.2.6.1 Mexico Nucleotide Market by Type
10.2.6.2 Mexico Nucleotide Market by Application
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Nucleotide Market by Country
10.3.1.2 Eastern Europe Nucleotide Market by Type
10.3.1.3 Eastern Europe Nucleotide Market by Application
10.3.1.4.1 Poland Nucleotide Market by Type
10.3.1.4.2 Poland Nucleotide Market by Application
10.3.1.5.1 Romania Nucleotide Market by Type
10.3.1.5.2 Romania Nucleotide Market by Application
10.3.1.6.1 Hungary Nucleotide Market by Type
10.3.1.6.2 Hungary Nucleotide Market by Application
10.3.1.7.1 Turkey Nucleotide Market by Type
10.3.1.7.2 Turkey Nucleotide Market by Application
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Nucleotide Market by Type
10.3.1.8.2 Rest of Eastern Europe Nucleotide Market by Application
10.3.2 Western Europe
10.3.2.1 Western Europe Nucleotide Market by Country
10.3.2.2 Western Europe Nucleotide Market by Type
10.3.2.3 Western Europe Nucleotide Market by Application
10.3.2.4.1 Germany Nucleotide Market by Type
10.3.2.4.2 Germany Nucleotide Market by Application
10.3.2.5.1 France Nucleotide Market by Type
10.3.2.5.2 France Nucleotide Market by Application
10.3.2.6.1 UK Nucleotide Market by Type
10.3.2.6.2 UK Nucleotide Market by Application
10.3.2.7.1 Italy Nucleotide Market by Type
10.3.2.7.2 Italy Nucleotide Market by Application
10.3.2.8.1 Spain Nucleotide Market by Type
10.3.2.8.2 Spain Nucleotide Market by Application
10.3.2.9.1 Netherlands Nucleotide Market by Type
10.3.2.9.2 Netherlands Nucleotide Market by Application
10.3.2.10.1 Switzerland Nucleotide Market by Type
10.3.2.10.2 Switzerland Nucleotide Market by Application
10.3.2.11.1 Austria Nucleotide Market by Type
10.3.2.11.2 Austria Nucleotide Market by Application
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Nucleotide Market by Type
10.3.2.12.2 Rest of Western Europe Nucleotide Market by Application
10.4.1 Asia Pacific Nucleotide Market by Country
10.4.2 Asia Pacific Nucleotide Market by Type
10.4.3 Asia Pacific Nucleotide Market by Application
10.4.4.1 China Nucleotide Market by Type
10.4.4.2 China Nucleotide Market by Application
10.4.5.1 India Nucleotide Market by Type
10.4.5.2 India Nucleotide Market by Application
10.4.6.1 Japan Nucleotide Market by Type
10.4.6.2 Japan Nucleotide Market by Application
10.4.7 South Korea
10.4.7.1 South Korea Nucleotide Market by Type
10.4.7.2 South Korea Nucleotide Market by Application
10.4.8.1 Vietnam Nucleotide Market by Type
10.4.8.2 Vietnam Nucleotide Market by Application
10.4.9.1 Singapore Nucleotide Market by Type
10.4.9.2 Singapore Nucleotide Market by Application
10.4.10.1 Australia Nucleotide Market by Type
10.4.10.2 Australia Nucleotide Market by Application
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Nucleotide Market by Type
10.4.11.2 Rest of Asia-Pacific Nucleotide Market by Application
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Nucleotide Market by Country
10.5.1.2 Middle East Nucleotide Market by Type
10.5.1.3 Middle East Nucleotide Market by Application
10.5.1.4.1 UAE Nucleotide Market by Type
10.5.1.4.2 UAE Nucleotide Market by Application
10.5.1.5.1 Egypt Nucleotide Market by Type
10.5.1.5.2 Egypt Nucleotide Market by Application
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Nucleotide Market by Type
10.5.1.6.2 Saudi Arabia Nucleotide Market by Application
10.5.1.7.1 Qatar Nucleotide Market by Type
10.5.1.7.2 Qatar Nucleotide Market by Application
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Nucleotide Market by Type
10.5.1.8.2 Rest of Middle East Nucleotide Market by Application
10.5.2.1 Africa Nucleotide Market by Country
10.5.2.2 Africa Nucleotide Market by Type
10.5.2.3 Africa Nucleotide Market by Application
10.5.2.4.1 Nigeria Nucleotide Market by Type
10.5.2.4.2 Nigeria Nucleotide Market by Application
10.5.2.5 South Africa
10.5.2.5.1 South Africa Nucleotide Market by Type
10.5.2.5.2 South Africa Nucleotide Market by Application
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Nucleotide Market by Type
10.5.2.6.2 Rest of Africa Nucleotide Market by Application
10.6 Latin America
10.6.1 Latin America Nucleotide Market by Country
10.6.2 Latin America Nucleotide Market by Type
10.6.3 Latin America Nucleotide Market by Application
10.6.4.1 Brazil Nucleotide Market by Type
10.6.4.2 Brazil Nucleotide Market by Application
10.6.5.1 Argentina Nucleotide Market by Type
10.6.5.2 Argentina Nucleotide Market by Application
10.6.6.1 Colombia Nucleotide Market by Type
10.6.6.2 Colombia Nucleotide Market by Application
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Nucleotide Market by Type
10.6.7.2 Rest of Latin America Nucleotide Market by Application
11. Company Profile
11.1 CJ CheilJedang Corporation
11.1.1 Company Overview
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Star Lake Bioscience Co. Inc
11.2.1 Company Overview
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 ThermoFisher Scientific Inc.
11.3.1 Company Overview
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Meihua Group
11.4 Company Overview
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 F. Hoffmann-La Roche Ltd
11.5.1 Company Overview
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Ajinomoto Co. Inc
11.6.1 Company Overview
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 DSM Nutritional Products Ltd.
11.7.1 Company Overview
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Promega Corporation
11.8.1 Company Overview
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Affymetrix Inc.
11.9.1 Company Overview
11.9.3 Product/Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 Agilent Technologies Inc.
11.10.1 Company Overview
11.10.3 Product/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
11.11 Nanjing BioTogether Co., Ltd.
11.11.1 Company Overview
11.11.3 Product/Services Offered
11.11.4 SWOT Analysis
11.11.5 The SNS View
11.12 NuEra Nutrition and Ohly GmbH
11.12.1 Company Overview
11.12.3 Product/Services Offered
11.12.4 SWOT Analysis
11.12.5 The SNS View
11.13 Glanbia Nutritional
11.13.1 Company Overview
11.13.3 Product/Services Offered
11.13.4 SWOT Analysis
11.13.5 The SNS View
12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Electronic Medical Record (EMR) systems market size was valued at US$ 28.02 billion in 2022 and is projected to reach over US$ 38.95 billion by 2030, with a growing CAGR of 4.2% during the forecast period 2023-2030.
The PET-CT Scanner Device Market size was estimated USD 2.3 billion in 2022 and is expected to reach USD 4.0 billion by 2030 at a CAGR of 7.2% during the forecast period of 2023-2030.
The Diet Pills Market size is expected to reach USD 3.04 Bn by 2030 and was valued at USD 1.45 Bn in 2022, the CAGR is expected to be 9.7% over the forecast period of 2023-2030.
The Electronic Health Records [EHR] Market size was esteemed at US$ 27.88 billion in 2022 and is projected to reach US$ 45.80 billion by 2030, enlisting a CAGR of 6.4% from 2023 to 2030.
The Wound Care Market Size was valued at USD 22.43 billion in 2022, and expected to reach USD 32.89 billion by 2030, and grow at a CAGR of 4.9% over the forecast period 2023-2030.
The Stomach Cancer Treatment Market size was estimated USD 4.3 billion in 2022 and is expected to reach USD 11.47 billion By 2030 at a CAGR of 13% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone